Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim PharmafiledCriticalBoehringer Ingelheim Pharma
Priority to UY26972ApriorityCriticalpatent/UY26972A1/en
Publication of UY26972A1publicationCriticalpatent/UY26972A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a nuevos compuestos de fórmula I, o a sus sales farmacéuticamente aceptables en donde R1 significa 3-hidroxipropilo, 1,3- dihidroxiprop-2-ilo o cicloalquil C3-C6-metilo y R2, R3, R4, y Ar poseen los significados indicados y empleo. Los nuevos compuestos son valiosos antagonistas de neuroquinina (taquiquinina)The invention relates to novel compounds of formula I, or to their pharmaceutically acceptable salts wherein R1 means 3-hydroxypropyl, 1,3-dihydroxypropyl-2-yl or C3-C6-methyl cycloalkyl and R2, R3, R4, and Ar possess the meanings indicated and employment. The new compounds are valuable neuroquinine antagonists (tachykinin)
UY26972A2001-10-162001-10-16
NEW NEUROQUININE ANTAGONISTS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
UY26972A1
(en)
PIPERAZINE COMPOUNDS AS TAQUININE ANTAGONISTS ITS SALTS AND SOLVATES PHARMACEUTICAL COMPOSITIONS CONTAINING THEIR USE AND PROCESSES FOR THEIR PREPARATION
COMPOUNDS DERIVED FROM 1,3-DIHIDRO-2H-INDOL-2-ONA, ITS USE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, MEDICINES CONSTITUTED BY SUCH COMPOUNDS AND INTERMEDIATE COMPOUNDS